These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38114732)

  • 1. Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy.
    Martini F; Spangaro M; Bechi M; Agostoni G; Buonocore M; Sapienza J; Nocera D; Ave C; Cocchi F; Cavallaro R; Bosia M
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; ():. PubMed ID: 38114732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role?
    Spangaro M; Martini F; Bechi M; Buonocore M; Agostoni G; Cocchi F; Sapienza J; Bosia M; Cavallaro R
    J Psychiatr Res; 2021 Sep; 141():346-352. PubMed ID: 34304039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia.
    Chan SKW; Pang TSW; Tsui HKH; Suen YN; Yan WC; Tsui CF; Poon LT; Chan CWH; Lo A; Cheung KM; Hui CLM; Chang WC; Lee EHM; Chen EYH; Honer WG
    Psychiatry Res; 2024 Jul; 337():115985. PubMed ID: 38820652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial.
    Wykes T; Newton E; Landau S; Rice C; Thompson N; Frangou S
    Schizophr Res; 2007 Aug; 94(1-3):221-30. PubMed ID: 17524620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
    Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial.
    Puig O; Penadés R; Baeza I; De la Serna E; Sánchez-Gistau V; Bernardo M; Castro-Fornieles J
    J Am Acad Child Adolesc Psychiatry; 2014 Aug; 53(8):859-68. PubMed ID: 25062593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia.
    Greenwood K; Hung CF; Tropeano M; McGuffin P; Wykes T
    Neurosci Lett; 2011 Jun; 496(2):65-9. PubMed ID: 21458532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
    de Bartolomeis A; Prinzivalli E; Callovini G; D'Ambrosio L; Altavilla B; Avagliano C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():356-366. PubMed ID: 28887181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?
    Lindenmayer JP; Khan A; McGurk SR; Kulsa MKC; Ljuri I; Ozog V; Fregenti S; Capodilupo G; Buccellato K; Thanju A; Goldring A; Parak M; Parker B
    Schizophr Res; 2018 Nov; 201():180-186. PubMed ID: 29910120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism.
    Spangaro M; Bosia M; Bechi M; Buonocore M; Cocchi F; Guglielmino C; Bianchi L; Mastromatteo A; Lorenzi C; Cavallaro R
    Schizophr Res; 2018 Dec; 202():106-110. PubMed ID: 30539765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances.
    Pillet B; Morvan Y; Todd A; Franck N; Duboc C; Grosz A; Launay C; Demily C; Gaillard R; Krebs MO; Amado I
    Disabil Rehabil; 2015; 37(10):846-53. PubMed ID: 25109501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Cognition to Increase Treatment Efficacy in Schizophrenia: Effects of Metabolic Syndrome on Cognitive Remediation's Outcome.
    Bosia M; Buonocore M; Bechi M; Santarelli L; Spangaro M; Cocchi F; Guglielmino C; Bianchi L; Bringheli S; Bosinelli F; Cavallaro R
    Front Psychiatry; 2018; 9():647. PubMed ID: 30581395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
    Iasevoli F; Giordano S; Balletta R; Latte G; Formato MV; Prinzivalli E; De Berardis D; Tomasetti C; de Bartolomeis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():34-48. PubMed ID: 26320028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Neuroanatomical Signatures of Patients With Treatment-Resistant Schizophrenia Compared to Patients With Early-Stage Schizophrenia and Healthy Controls.
    Liu C; Kim WS; Shen J; Tsogt U; Kang NI; Lee KH; Chung YC
    Front Psychiatry; 2022; 13():802025. PubMed ID: 35664476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial.
    Franck N; Duboc C; Sundby C; Amado I; Wykes T; Demily C; Launay C; Le Roy V; Bloch P; Willard D; Todd A; Petitjean F; Foullu S; Briant P; Grillon ML; Deppen P; Verdoux H; Bralet MC; Januel D; Riche B; Roy P; ; Vianin P
    Schizophr Res; 2013 Jun; 147(1):68-74. PubMed ID: 23583327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.